Lucid Motors Appoints Nick Twork as Head of Global Communications

Lucid Group, Inc. (NASDAQ: LCID), a pioneer in advanced electric vehicles, proudly announces the appointment of Nick Twork as Head of Global Communications. Twork brings over two decades of strategic communication and marketing expertise from leading automotive and technology sectors worldwide. In his new role, Nick Twork will oversee Lucid’s comprehensive global communications strategy, encompassing…

Read More

Shane Portfolio Named Chief Technology Officer of Congruex, Elevating Digital Network Expertise

Congruex, a leading provider of comprehensive digital network services, has appointed Shane Portfolio as its new Chief Technology Officer. With an illustrious career marked by transformative leadership in digital network engineering, Portfolio joins Congruex to spearhead technological innovation and extend nationwide connectivity solutions. Shane Portfolio brings nearly three decades of profound industry experience, cultivated during…

Read More

RareCyte Secures $20M to Expand Orion™ Spatial Biology Platform and Precision Biology Services

RareCyte, Inc., a pioneering Life Sciences company renowned for its Precision Biology platforms, has announced the successful completion of a $20 million financing round aimed at bolstering its Orion™ Spatial Biology platform. This funding, sourced from a blend of new and existing investors, including Forest Road, Arboretum Ventures, and F-Prime Capital, underscores RareCyte’s commitment to…

Read More

Gradient AI Secures $56 Million in Series C Round to Drive Innovation in AI-Powered Insurance Solutions

Gradient AI, a premier enterprise software provider specializing in artificial intelligence for the insurance sector, has successfully closed a Series C funding round, securing $56.1 million. This substantial investment, spearheaded by Centana Growth Partners and supported by existing investors MassMutual Ventures, Sandbox Insurtech Ventures, and Forte Ventures, is poised to significantly bolster the company’s capabilities…

Read More
CEO Greg Loos and Co-founder Linda Miller

TrackLight Secures $3M Seed Funding to Revolutionize Fraud Prevention with AI-Powered Platform; Unveils AI Co-Pilot Ray the Parrot

TrackLight, a trailblazer in AI-driven fraud detection and prevention, has launched its innovative platform aimed at combatting fraud across government and corporate sectors. The company also announced a significant milestone with a $3 million Seed funding round led by BarronKent and Growth Factory. This investment is set to accelerate TrackLight’s platform development, sales initiatives, and…

Read More

HEPTA Medical Secures €5.7 Million in Series A Funding to Revolutionize Lung Cancer Treatment

In a significant boost to the fight against lung cancer, HEPTA Medical, a pioneering medical device company specializing in minimally invasive thermal ablation therapy, has successfully completed a €5.7 million Series A funding round. The investment was led by BPI France and supported by M&L Healthcare and Clery IG. Founded in 2019 by Sofinnova Partners…

Read More

DeepDrive Secures €30M Series B Funding to Revolutionize EV Motors

In a significant advancement for the electric vehicle (EV) landscape, DeepDrive, a cutting-edge electric motor technology company, has successfully raised €30 million in a Series B funding round. This round was spearheaded by Leitmotif, an independent venture capital firm dedicated to decarbonization efforts across the U.S. and Europe, with notable participation from existing investors including…

Read More

Presti Secures $3.5M Seed Funding to Transform Product Photography with AI

Presti, a pioneering startup in AI-generated product photography, has announced the successful closure of a $3.5 million Seed funding round led by Partech and supported by several notable angel investors. This funding round marks a significant milestone for the company, positioning it to revolutionize the e-commerce industry with its innovative approach to high-quality imagery. Founded…

Read More

Cardurion Pharmaceuticals Secures $260 Million Series B to Advance Cardiovascular Drug Pipeline

Cardurion Pharmaceuticals, a pioneering biotechnology firm specializing in innovative therapies for cardiovascular diseases, has announced the successful completion of a $260 million Series B financing round. Led by Ascenta Capital and supported by a consortium of esteemed investors including NEA, GV, and Fidelity Management & Research Company, this substantial funding underscores Cardurion’s commitment to advancing…

Read More